Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Normal Saline Nasal Spray Dexmedetomidine Injection Intravenous Propofol Injection Sufentanil Injection

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07204106Not ApplicableCompleted

Efficacy Study of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in ERCP

NCT03587545Not ApplicableUnknown

Study of Probiotic Potential of Lactobacillus Strains in the Upper Respiratory Tract After Nasal Spray Application

Showing all 2 trials

Research Network

Common Treatments

  • Normal Saline Nasal Spray Dexmedetomidine Injection Intravenous Propofol Injection Sufentanil Injection1
  • Dexmedetomidine Injection Nasal Spray Propofol Injection Sufentanil Injection1
  • Probiotic Nasal Spray1
  • Regular Sedation Protocol1

Active Sponsors

  • University Hospital, Antwerp1
  • Shiyou Wei1
  • Shanghai East Hospital of Tongji University1

Top Investigators

Related Conditions

  • Chronic Rhinosinusitis Diagnosis1
  • Healthy Volunteers1
  • Nasal Disease1
  • Nasal Administration1
  • Probiotics1

Activity Timeline